NNVC NANOVIRICIDES, INC.
Pharmaceutical Preparations · NYSE · SEC CIK 1379006 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-49.9%
TTM EPS YoY-8.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-179.2%
ROA-135.9%
ROIC (approx.)-196.2%
Asset turnover0.00x
Leverage & solvency
Liabilities / assets33.5%
Debt / equity0.00x
Current ratio0.95x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.80x
Accruals ratio-27.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $0 |
| R&D expense | $4.71M | $5.55M |
| SG&A expense | $3.60M | $4.04M |
| Operating income | -$8.31M | -$9.59M |
| Interest expense | — | $149 |
| Pretax income | -$8.22M | — |
| Net income | -$8.22M | -$9.47M |
| EBITDA | -$7.79M | -$8.86M |
| EPS (basic) | -0.41 | -0.63 |
| EPS (diluted) | -0.41 | -0.63 |
| Weighted avg. shares (diluted) | 20.19M | 15.12M |
| Balance sheet | ||
| Cash & equivalents | $2.79M | $1.56M |
| Current assets | $3.16M | $1.67M |
| PP&E, net | $6.40M | $6.83M |
| Intangibles | $308,769 | $317,039 |
| Total assets | $9.87M | $8.82M |
| Current liabilities | $1.19M | $1.31M |
| Total liabilities | $1.20M | $1.30M |
| Shareholders' equity | $8.68M | $7.52M |
| Shares outstanding | 23.01M | 16.61M |
| Cash flow statement | ||
| Operating cash flow | -$7.70M | -$8.48M |
| Capital expenditure | $84,317 | $56,964 |
| Free cash flow | -$7.78M | -$8.54M |
| Investing cash flow | -$84,317 | -$56,964 |
| Financing cash flow | $9.02M | $5.30M |
| Depreciation & amortization | $517,016 | $735,536 |
Free plan shows the latest 2 periods; Pro shows all 21 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.